Elizabeth White, PhDChief Operating Officer and Co-Founder, Orphan Therapeutics Accelerator, Inc. at Chief Commercial Officer, Orphan Therapies LLCSpeaker
Profile
Beth White is a highly experienced biopharmaceutical senior executive with a unique ability to bridge business strategy and scientific innovation who has made a smooth transition from large pharma to entrepreneurial biotech. Beth has built a very broad skill set gained through leadership roles over a
37-year career spanning drug development, portfolio prioritization, strategic planning, new company formation, business development, operations, corporate communications, commercial planning, and global brand management. With a specialized understanding of genetic medicines and gene therapy, she is experienced in many therapeutic areas with strong expertise in rare diseases. She is dedicated to helping emerging biotechnology companies successfully and efficiently translate their innovative technologies into accessible medicines that will help patients in need.
Agenda Sessions
Commercializing Breakthrough Modalities – Gene and Cell Therapy in Ultra Rare Disease
, 5:00pmView Session
